Shearman & Sterling advised Vitruvian Partners on its acquisition of CRF Health from Verdane funds for an undisclosed sum.
CRF Health is the leading provider of electronic Clinical Outcome Assesments (eCOA) solutions for the life sciences industry with experience in about 550 trials, over 100 languages and across 74 countries.
Vitruvian is an independent private equity firm that specializes in middle-market buyouts, growth buyouts and growth capital investments in the UK and elsewhere in Northern Europe. Vitruvian’s expertise as principals in the industry dates back to 1990.
Recently, Shearman & Sterling advised Vitruvian on the acquisition of JacTravel (July 2014).